1. University/British Heart Foundation Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
2. Division of Valvular and Coronary Disease, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet and University Hospital Stockholm, Stockholm, Sweden
3. INSERM U1116, University of Lorraine, Nancy University Hospital, Nancy, France
4. Department of Pathology, Academic Medical Hospital, University of Amsterdam, Amsterdam, The Netherlands
5. Laboratory of Experimental Cardiology and Laboratory of Clinical Chemistry and Hematology, UMC Utrecht, Utrecht, Netherlands
6. Department of Cardiovascular Science, KU Leuven, Leuven, Belgium
7. Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
8. Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
9. Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland
10. Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
11. Max Planck Institute for Molecular Biomedicine, Muenster, Germany
12. Cells-in-Motion Cluster of Excellence (EXC 1003–CiM), University of Muenster, Muenster, Germany
13. Department of Pathology, CARIM, Maastricht University Medical Center, Maastricht, The Netherlands
14. Ludwig-Maximilians-University, German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
15. IIS-Fundación Jiménez Díaz, Madrid, Spain
16. Autónoma University, Madrid, Spain
17. INSERM U1048/Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
18. Department of Cardiology, Biomechanics Laboratory, Erasmus MC, Rotterdam, The Netherlands
19. A.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland
20. Heart Center and Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland
21. Department of Infection, Immunity and Cardiovascular Disease, Faculty of Medicine, Dentistry and Health, the INSIGNEO Institute for In Silico Medicine and the Bateson Centre, University of Sheffield, Sheffield, UK